Suchergebnisse - Dexamethasone OR corticosteroid

PubPharm (9.858)

1311

Development of UPLC method for simultaneous assay of some COVID-19 drugs utilizing novel instrumental standard addition and factorial design

enthalten in: Scientific reports | 2023

von El-Shorbagy, H. | Mohamed, M. | El-Gindy, A. | +2

1312

COrticosteroids for COVID-19 induced loss of Smell : COrticosteroids for COVID-19 induced loss of Smell (COCOS trial)

enthalten in: WHO International Clinical Trials Registry Platform | 2023

1313

Posterior Scleritis Following COVID-19 Vaccination : A Case Report

enthalten in: Ocular immunology and inflammation | 2023

von Younus, O. | Mulla, U.

1314

Management of neonatal sepsis with COVID-19 infection in a premature newborn - A case report

enthalten in: Journal of neonatal nursing : JNN | 2023

von Kaveh, M. | Sadatinejad, S.

1315

Dexamethasone for Inpatients With COVID-19 in a National Cohort

enthalten in: JAMA network open | 2023

von Mourad, A. | Thibault, D. | Holland, T. | +4

1316

Characteristics of Suspected COVID-19 Discharged Emergency Department Patients Who Returned During the First Wave

enthalten in: The western journal of emergency medicine | 2023

von Gong, J. | Mayorga, R. | Hentz, R. | +9

1317

COrticosteroids for COVID-19 induced loss of Smell : COrticosteroids for COVID-19 induced loss of Smell (COCOS trial)

enthalten in: WHO International Clinical Trials Registry Platform | 2023

1318

Multiple Organ Dysfunction Secondary to Herpes Simplex Virus -1 Reactivation After Treatment With Dexamethasone and Sarilumab for Covid-19 Disease

enthalten in: The Journal of critical care medicine | 2023

von Roe, T. | Waddy, S. | Nikitas, N.

1319

COVID-19 : A Review of Potential Treatments (Corticosteroids, Remdesivir, Tocilizumab, Bamlanivimab/Etesevimab, and Casirivimab/Imdevimab) and Pharmacological Considerations

enthalten in: Journal of pharmacy practice | 2023

von Nhean, S. | Varela, M. | Nguyen, Y. | +4

1320

Therapeutic Drug Monitoring and Dosage Adjustments of Immunosuppressive Drugs When Combined With Nirmatrelvir/Ritonavir in Patients With COVID-19

enthalten in: Therapeutic drug monitoring | 2023

von Lemaitre, F. | Budde, K. | Van Gelder, T. | +14